Clinical Trial Update: A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness and safety of subcutaneous ustekinumab (Stelara) with CNTO 1959 in patients with active rheumatoid arthritis on top o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CNTO 1959
• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2014-12-19